Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2

Effect of Perindopril on Atrial Fibrillation Recurrence and Burden: Results of the Canadian Trial of Atrial Fibrillation (CTAF)-2

Background: Hypertension is a risk factor for the development and exacerbation of atrial fibrillation (AF). Angiotensin-converting enzyme inhibitors are a standard-of-care treatment option for patients with hypertension; however, there is conflicting evidence about their effects on AF recurrence. Th...

Full description

Bibliographic Details
Main Authors: Lena Rivard, MD, MSc, Michelle Samuel, MPH, PhD, Annik Fortier, MSc, Marie-Claude Guertin, PhD, Paul Khairy, MD, PhD, Denis Roy, MD, Mario Talajic, MD, Jean-Claude Tardif, MD
Format: Article
Language:English
Published: Elsevier 2021-09-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X21001220

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X21001220

Similar Items